Chemo Drugs 3 Flashcards

1
Q
Doxorubicin 
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: antitumor antibiotic
Cycle specificity: CCNS
Macromolecular target: DNA
Bioactivation: None
MOA: Intercalation between base pairs of DNA leading to strand breaks due to inhibition of topoisomerase 2
Pharmacokinetics and metabolism: metabolized by the liver and excreted as a thiol adduct into the bile
Side effects:
1. N/V hair loss, stomatitis
2. Myelosuppression is dose limiting
2. Cardiac toxicity: congestive cardiomyopathy-determine ejection fraction prior to institution of treatment with doxorubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the special features of doxorubicin? What is doxorubicin used for?

A
  1. the drug is a vesicant
  2. must dose reduce in the presence of jaundice
  3. durg has a cumulative cardiac toxicity
    - lifetime dose

Uses:
breast cancer, leukemia, sarcoma, Hodgkin’s and non hodgkin’s lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of toxicity does doxorubicin have? What drug is cardioprotective agent in patients receiving doxorubicin?

A

schedule dependent cardiac toxicity

  • less toxicity if administered slowly
  • schedule independent cytotoxicity

Cardioprotective= dexrazoxane-iron chelator-decrease in free radical damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Topoisomerase 1 inhibitors

Topotecan and irinotecan

A

Single strand DNA breaks, relaxation of the strand and re-anneal the strands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Topoisomerase 2 inhibitors

Intercalators: daunomycin, doxorubicin, mitoxantrone, dactinomycin

Non intercalators:
etoposide

A

Double strand breaks in DNA, relaxation and re-anneal of strands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intercalating and non intercalating topoisomerase 2 inhibitors and tubulin inhibitors are cross resistant to what? What can help with the resistance?

A

MDR-the p-glycoprotein is a membrane bound efflux pump

  • giving continuously may help downregulate the glycoprotein and reverse resistance
  • quinine, verapamil, cyclosporine may block the efflux pump and reverse resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
Irinotecan
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: (camptothecin, plant alkaloid)

Cycle specificity: CCNS

Macromolecular target: DNA

Bioactivation: Prodrug. Converted by carboxylesterase to 7 ethyl 10 hydroxycamptothecin (SN-38)

MOA: topoisomerase 1 inhibition leading to single stranded breaks in the DNA

Pharmacokinetics and metabolism:
hepatic metabolism is significant. Dose reduction required for jaundice. UGTIA1 is responsible for clearance by glucuronidation of drug and bilirubin (severe neutropenia in Gilbert’s syndrome-UGT1A1 polymorphism)

Side effects:

  1. Nausea, vomiting, stomatitis
  2. Myelosuppression dose limiting
  3. Early cholinergic diarrhea (treated with atropine)
  4. Late secretory diarrhea (treated with Imodium-deaths have occurred)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are special features of Irinotecan?

A

Decrease dose of drug in the presence of jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the uses of Irinotecan?

A

Colon cancer

Topotecan (ovarian and small cell lung cancers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
Bleomycin
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: Antitumor antibiotic

Cycle specificity: CCS

Macromolecular target: DNA

Bioactivation: None

MOA: Binds to DNA, free radical production leading to single and double stranded DNA breaks. The bleomycin-iron form is the active species.

Pharmacokinetics and metabolism: 50% excreted in the urine. the liver and kidneys rapidly inactivate the drug. The lungs and the skin have very low levels of the inactivating enzyme

Side effects:

  1. PULMONARY TOxicity-dose limiting
    - decrease in pulmonary diffusion capacity
  2. hyperpigmentation of skin, hyperkeratosis of the palms
  3. stomatitis and hair loss.
  4. NOT myelosuppressive
  5. anaphylactoid reactions have been noted with first dose in patients with lymphoma
  6. fever chills common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Special features and dose modifications for bleomycin

A
  1. test dose is given before first dose is administered to monitor for severe reactions
  2. cumulative pulmonary toxicity
  3. baseline pulmonary function test prior to institution
  4. avoid administering high oxygen concentrations
  5. dose reductions must be made for renal insufficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does bleomycin treat?

A

testicular cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Prednisone
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: Steroid

Cycle specificity: N/A

Macromolecular target: steroid receptor

Bioactivation: None

MOA: unknown

Pharmacokinetics and metabolism: N/A

Side effects: Weight gain, hypertension, edema, carbohydrate intolerance. suppression of pituitary-adrenal axis, weakness, euphoria, increased appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is prednisone used to treat?

A

Hodgkin’s disease and non-Hodgkin’s lymphoma

-also used in multiple myeloma and some forms of leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dexamethasone

A

used along with 5-HT3 inhibitors to prevent or ameliorate chemotherapy treatment related nausea and vomiting

  • less mineralocorticoid effects than prednisone
  • used to treat cerebral edema or spinal cord edema due to spinal cord compression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Tamoxifen
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: hormonal agent, SERM

Cycle specificity: NA

Macromolecular target: Estrogen receptor in cancer (usually breast cancer). Mixed agonist/antagonist

Bioactivation: prodrug and is metabolized in liver to 4-hydroxytamoxifen

MOA: binds to the estrogen receptor in the cancer cell

Pharmacokinetics and metabolism: metabolized by the liver

Side effects: some weight gain, hot flashes, endometrial cancer, thrombosis

17
Q

Special features of Tamoxifen

A
  1. Tamoxifen is approved as chemoprevention in women at high risk of developing breast cancer
  2. mildly estrogenic-favorable lipid and decreased rate of bone loss postmeno
18
Q

What are the uses of tamoxifen?

A

breast cancer

19
Q
Anastrozole
Class:
Cycle specificity:
Macromolecular target:
Bioactivation:
MOA:
Pharmacokinetics and metabolism:
Side effects:
A

Class: aromatase inhibitor

Cycle specificity: NA

Macromolecular target: aromatase

Bioactivation: None

MOA: selective nonsteroidal inhibitor of aromatase produces marked lowering of plasma estrogen levels

Pharmacokinetics and metabolism: estradiol levels reduced by 70% in 24 hours and 80% after 2 weeks. metabolized extensively by live. no dose adjust for liver or renal dysfunction

Side effects: hot flashes, mood disturbances, arthritis, arthralgias, bone pain, bone loss, osteoporosis

20
Q

Uses of Anastrozole

A

Oral administration. hormone receptor positive breast cancer (adjuvant and metastasis)

21
Q

Flutamide
Class:
MOA:
Side effects:

A

Class: flutamide

MOA: inhibits the uptake and binding of testosterone to specific receptors in hormonally sensitive prostate cancer cells

Side effects: well tolerated. Diarrhea (20% of patients-bicalutamide-less) and elevations of liver transaminases

22
Q

Uses of flutamide

A

Oral administration and used in the ADT (androgen deprivation treatment) therapy of metastatic prostate cancer

23
Q

Leuprolide acetate
Class:
MOA:
Side effects:

A

Class: GnRh receptor agonist

MOA: binds to pituitary GnRH receptors and initially produces an increase in LH and FSH leading to an increase in testosterone and thus initially can stimulate tumor growth. by interruptions the pulsatile stimulation of GnRH receptors, leuprolide down regulates the secretion of gonadotropins LH and FSH leading to a reduction in testosterone levels

Side effects: hot flashes. decreased libido, loss of muscle mass, erectile dysfunction, change in body fat distribution, gynecomastia

24
Q

special features of leuprolide

A
  • patient initially treated with flutamide or bicalutamide for 2-4 weeks before starting leuprolide to avoid flare then stopped
  • given intramuscularly-depot form available